Aequus Pharmaceuticals Statistics
Total Valuation
AQSZF has a market cap or net worth of 478,541. The enterprise value is 5.21 million.
| Market Cap | 478,541 |
| Enterprise Value | 5.21M |
Important Dates
The last earnings date was Friday, August 29, 2025.
| Earnings Date | Aug 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 132.63M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 113.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.80 |
| PB Ratio | -0.09 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.33 |
| EV / Sales | 8.87 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.03
| Current Ratio | 0.03 |
| Quick Ratio | 0.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.69 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -103.81% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 15.10% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 12 |
| Asset Turnover | 1.31 |
| Inventory Turnover | 2.69 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.33% in the last 52 weeks. The beta is -0.30, so AQSZF's price volatility has been lower than the market average.
| Beta (5Y) | -0.30 |
| 52-Week Price Change | -77.33% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 47.72 |
| Average Volume (20 Days) | 34,237 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AQSZF had revenue of 597,594 and -1.20 million in losses. Loss per share was -0.01.
| Revenue | 597,594 |
| Gross Profit | 341,982 |
| Operating Income | -758,366 |
| Pretax Income | -1.20M |
| Net Income | -1.20M |
| EBITDA | n/a |
| EBIT | -758,366 |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 25,720 in cash and 4.87 million in debt, giving a net cash position of -4.84 million.
| Cash & Cash Equivalents | 25,720 |
| Total Debt | 4.87M |
| Net Cash | -4.84M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -5.33M |
| Book Value Per Share | -0.04 |
| Working Capital | -5.02M |
Cash Flow
| Operating Cash Flow | -325,046 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 57.23%, with operating and profit margins of -126.90% and -201.41%.
| Gross Margin | 57.23% |
| Operating Margin | -126.90% |
| Pretax Margin | -201.41% |
| Profit Margin | -201.41% |
| EBITDA Margin | n/a |
| EBIT Margin | -126.90% |
| FCF Margin | n/a |
Dividends & Yields
AQSZF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -251.52% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AQSZF has an Altman Z-Score of -257.28 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -257.28 |
| Piotroski F-Score | 3 |